13 February 2019 - During President Trump’s State of the Union speech, he spoke about the urgent need to lower prescription drug prices. 

He talked about global freeloading and the injustice of Americans paying more for drugs that are made here than foreign countries do. He discussed the need for price transparency, where drug manufacturers reveal their list prices on television ads and elsewhere. The president also discussed the need for legislation that ensures drug discounts are transferred directly to the consumer.

Under the current system, middle managers, like pharmacy benefit managers and insurers negotiate prices with the drug companies.

Read The Hill article